Biotech Finances: "Acticor moves forward and comes back to crowdfunding!"
March, 14th 2016. Biotech Finances publishes an article on…
Acticor Biotech selects Catalent GPEx® Cell Line Development Technology to develop ACT-017
Acticor Biotech is developing an antibody fragment (Fab)…
Blood Journal: Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation
Platelet glycoprotein VI binds to polymerized fibrin and promotes…
BioPharmAnalyses.fr: French crowdfunding supports Acticor Biotech
Le crowdfunding français soutient Acticor Biotech
By Anne Lise…
Les Echos.fr: Crowdfunding: new platforms, new projects
Crowdfunding : nouvelles plates-formes, nouveaux projets
By Marie-Christine…
Biotech Finances : Acticor Biotech collects 590k€ to start its preclinical development
Acticor Biotech Collecte 590 K€ Pour Son Entrée En Pré-Clinique
By Hélène…
LABIOTECH.fr: Acticor Biotech wins its crowdfunding bet!
Acticor Biotech réussi le pari du crowdfunding!
By Joachim –…
Acticor Biotech bets on crowdfunding for health and successfully raises its first seed round
The company is seeking to develop a monoclonal antibody with
antiplatelet…
